Company Overview of Hydra Biosciences, Inc.
Key Executives for Hydra Biosciences, Inc.
|Russell H. Herndon||24 Relationships||Chief Executive Officer, President and Director||57|
|David E. Clapham M.D., Ph.D.||27 Relationships||Scientific Co-Founder, Chair of Scientific Advisory Board and Member of Pain Medical Advisory Board||--|
|Mark T. Keating M.D.||13 Relationships||Scientific Co-Founder and Member of Scientific Advisory Board - Cardiac Regeneration||--|
|Thomas Joseph Burke||No Relationships||Chief Financial Officer and Treasurer||--|
|Bertrand L. Chenard Ph.D.||No Relationships||Senior Vice President of Chemistry, Pharmacology and Preclinical Development||60|
|View More Key Executives|
Hydra Biosciences, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Robert J. Carpenter||87 Relationships||REC, Inc.||70|
|Russell H. Herndon||24 Relationships||Hydra Biosciences, Inc.||57|
|Mark T. Keating M.D.||13 Relationships||Hydra Biosciences, Inc.||--|
|David E. Clapham M.D., Ph.D.||27 Relationships||Hydra Biosciences, Inc.||--|
|Michael Sanguinetti Ph.D.||19 Relationships||Hydra Biosciences, Inc.||--|
Hydra Biosciences, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Advisory Board M.D., Ph.D.||David E. Clapham||27 Relationships||9 Executives|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.